Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting

Keep reading

Mendus AB: Live webcast to discuss clinical results of ADVANCE II trial presented at ASH 2022